Sharia Hernandez Ruiz

9PUBLICATIONS
123CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursCancer diagnosisGenomics and transcriptomicsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 29, 2026
A pilot translational study of neoadjuvant fulvestrant plus abemaciclib in women with advanced low-grade serous carcinoma.

|May 28, 2026
Pan-cancer spatial atlas of tertiary lymphoid structures.

|Apr 21, 2026
AI-Powered Deep Visual Proteomics Reveals Critical Molecular Transitions in Pancreatic Cancer Precursors.

|Sep 26, 2025
Comparison of imaging based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed paraffin-embedded tumor samples.

Nejla Ozirmak Lermi, Max Molina Ayala, Sharia Hernandez

|Aug 20, 2025
Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy.

Erez N Baruch, Frederico O Gleber-Netto, Priyadharsini Nagarajan

|Apr 27, 2025
Improved overall survival in an anti-PD-L1 treated cohort of newly diagnosed glioblastoma patients is associated with distinct immune, mutation, and gut microbiome features: a single arm prospective phase I/II trial.

Shiao-Pei Weathers, Xiqi Li, Haifeng Zhu

Pageof 2

Frequent Collaborators

5 joint publications

Luisa Maren Solis Soto

4 joint publications

Andrew P Futreal

3 joint publications

Linghua Wang

3 joint publications

Nejla Ozirmak Lermi